Filing Flows › Orthofix Medical (OFIX) › Q3 FY26 › vs Q2 FY26
Orthofix Medical (OFIX) Q3 FY26 vs Q2 FY26 (quarter over quarter)
Orthofix Medical's revenue fell $3.1M (-1%) from $211M in Q2 FY26 to $208M in Q3 FY26. The biggest changes: Global Spine −$1.8M (-1%); Global Limb Reconstruction −$1.3M (-3%).
Orthofix Medical, Q3 FY26: revenue $208M (+1% year over year), operating margin 0.7%, net loss $6.1M, operating cash flow $363K. The chart draws each line against Q2 FY26, the increases inside each band.
Every line
| Line | Q3 FY26 | Q2 FY26 | Change | % |
|---|---|---|---|---|
| Global Spine | $171M | $173M | −$1.8M | -1% |
| Global Limb Reconstruction | $36.4M | $37.7M | −$1.3M | -3% |
| Revenue | $208M | $211M | −$3.1M | -1% |
| Net loss | $6.1M | $15.8M | −$9.7M | -62% |
| Costs & expenses | $214M | $227M | −$12.8M | -6% |
| Operating costs | $206M | $219M | −$12.8M | -6% |
| Interest & other, net | $6.8M | $6.9M | −$70K | -1% |
| Income tax | $826K | $801K | $25K | +3% |
| Cost of revenue | $61.3M | $61.2M | $90K | +0.1% |
| Research & development | $15.3M | $15.9M | −$667K | -4% |
| SG&A | $125M | $138M | −$12.7M | -9% |
| Other operating costs | $4.4M | $3.9M | $527K | +14% |
| Operating cash sources | $19.9M | $21.0M | −$1.1M | -5% |
| Depreciation & amortization | $13.2M | $13.3M | −$101K | -0.8% |
| Share-based compensation | $6.7M | $7.7M | −$991K | -13% |
| Net loss absorbed | $6.1M | $15.8M | −$9.7M | -62% |
| Working capital & other | $13.5M | $11.4M | $2.0M | +18% |
| Operating cash flow | $363K | −$6.2M | $6.6M | — |
| Capital expenditures | $14.5M | $12.6M | $1.9M | +15% |
| Negative free cash flow (OCF − capex) | $14.1M | $18.9M | −$4.7M | -25% |
Questions
How much did Orthofix Medical's revenue grow quarter over quarter in Q3 FY26?
Orthofix Medical's revenue fell $3.1M (-1%) from $211M in Q2 FY26 to $208M in Q3 FY26.
What drove Orthofix Medical's revenue change in Q3 FY26?
Global Spine −$1.8M (-1%); Global Limb Reconstruction −$1.3M (-3%).